Log In
BCIQ
Print this Print this
 

PTL-202

  Manage Alerts
Collapse Summary General Information
Company Pacific Therapeutics Ltd.
DescriptionSpecifically formulated combination of two compounds: pentoxifylline and vitamin E
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationPulmonary fibrosis
Indication DetailsTreat idiopathic pulmonary fibrosis (IPF); Treat radiation-induced fibrosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today